Somatostatin-28 (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)
目录号 : GC49574A cyclic neuropeptide hormone
Sample solution is provided at 25 µL, 10mM.
Somatostatin-28 is a cyclic neuropeptide hormone that has a role in endocrine regulation.1 It is a somatostatin (SST) receptor agonist that binds to SST1, SST2, SST3, SST4, and SST5 (IC50s = 0.60, 0.12, 0.22, 0.83, and 0.41 nM, respectively, in CCL39 cells expressing human recombinant receptors).2 It inhibits cAMP accumulation induced by forskolin in CCL39 cells expressing human recombinant SST1, SST2, SST3, SST4, and SST5 (EC50s = 5.13, 1.91, 6.46, 2.95, and 3.55 nM, respectively).3 Somatostatin-28 stimulates growth hormone (GH) release from primary porcine pituitary cells when used at a concentration of 1 fM.4 It inhibits acid secretion induced by gastrin I and IBMX in isolated rat gastric mucosa (EC50s = 27 and 252 nM, respectively).5 In vivo, somatostatin-28 dose-dependently increases basal and pentagastrin-induced gastric acid secretion in rats.6
1.Lucey, M.R.Endogenous somatostatin and the gutGut27(4)457-467(1986) 2.Siehler, S., Seuwen, K., and Hoyer, D.Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studiesNaunyn Schmiedebergs Arch. Pharmacol.360(5)488-499(1999) 3.Siehler, S., and Hoyer, D.Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activityNaunyn Schmiedebergs Arch. Pharmacol.360(5)510-521(1999) 4.RamÍrez, J.L., Torronteras, R., CastaÑo, J.P., et al.Somatostatin plays a dual, stimulatory/inhibitory role in the control of growth hormone secretion by two somatotrope subpopulations from porcine pituitaryJ. Neuroendocrinol.9(11)841-848(1997) 5.Wyatt, M.A., Jarvie, E., Feniuk, W., et al.Somatostatin sst2 receptor-mediated inhibition of parietal cell function in rat isolated gastric mucosaBr. J. Pharmacol.119(5)905-910(1996) 6.Seefried, G., Schmidtler, J., and Schwille, P.O.Gastric secretion and gastrin under progressive doses of somatostatin-14 and -28 administered intraperitoneally to the ratPeptides9(2)249-255(1988)
Cas No. | N/A | SDF | Download SDF |
Canonical SMILES | [H]N[C@@H](CO)C(N[C@H](C(N[C@@H](CC(N)=O)C(N[C@@H](CO)C(N[C@@H](CC(N)=O)C(N1CCC[C@H]1C(N[C@H](C(N[C@H](C(N[C@H](C(N2CCC[C@H]2C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@H](C(NCC(N[C@H](C(N[C@@H](CCCCN)C(N[C@@H](CC(N)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCCCN)C(N[C@]([C@@H](C)O)([H])C(N[C@H](C(N[C@]([C@@H](C)O)([H])C(N[C@@H](CO)C3=O)=O)=O)CC4=CC=CC=C4)=O)=O)=O)CC5=CNC6=C5C=CC=C6)=O)CC7=CC=CC=C7)=O)CC8=CC=CC=C8)=O)=O)=O)CSSC[C@H](N3)C(O)=O)=O)=O)C)=O)=O)=O)=O)=O)=O)C)=O)CCSC)=O)C)=O)=O)=O)=O)=O)C)=O.FC(F)(C(O)=O)F | ||
分子式 | C137H207N41O39S3 • XCF3COOH | 分子量 | 3148.6 |
溶解度 | Formic Acid: 1 mg/ml | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 0.3176 mL | 1.588 mL | 3.176 mL |
5 mM | 0.0635 mL | 0.3176 mL | 0.6352 mL |
10 mM | 0.0318 mL | 0.1588 mL | 0.3176 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet